Frontline plc Stock
Price
Target price
€31.50
€31.50
-6.940%
-2.35
-6.940%
€38.32
19:29 / Tradegate
WKN: A3D38W / Symbol: FRO / Name: Frontline / Stock / Transport Infrastructure / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Frontline
sharewise wants to provide you with the best news and tools for Frontline, so we directly link to the best financial data sources.
Financials
News
Tanker Dividends Are Surging, But Income Investors Need to Watch the Cycle
Key Points
- Interested in Frontline PLC? Here are five stocks we like better.
- Frontline, Nordic American Tankers, and Euroseas all raised dividends recently, with Frontline boosting its payout by
Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near
Key Points
- Interested in Corbus Pharmaceuticals Holdings, Inc.? Here are five stocks we like better.
- Corbus Pharmaceuticals highlighted encouraging Phase 1 data for CRB-701 in cervical and
Apogee Therapeutics Readies Zumi for Phase 3 With Blackstone Backing
Key Points
- Interested in Apogee Therapeutics Inc.? Here are five stocks we like better.
- Apogee Therapeutics plans to advance lead drug zumilokibart (Zumi) into Phase 3 later this year after
Frontline Q1 Earnings Call Highlights
Key Points
- Interested in Frontline PLC? Here are five stocks we like better.
- Frontline posted its most profitable quarter since 2004, reporting Q1 2026 profit of $559 million, or $2.51 per
Black Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 Study
Key Points
- Interested in Black Diamond Therapeutics, Inc.? Here are five stocks we like better.
- Black Diamond Therapeutics said its Phase 2 silevertinib study in treatment-naive non-small cell
Zebra Technologies Q1 Earnings Call Highlights
Zebra Technologies (NASDAQ:ZBRA) reported stronger-than-expected first-quarter results and raised its full-year outlook, citing broad